PGHHProcter & Gamble Hygiene and Health Care Limited
FMCG · Household & Personal Products · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on PGHH — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 36/100)
- • Revenue growth: -5.1% YoY
- • Profit growth: -1.9% YoY
- • RSI: 19
- • MACD: bearish
Bull case
- • ROE: 114.9%
- • ROCE: 150.3%
- • Debt/Equity: 0.00
- • Trend strength (ADX): 44
Bear case
- • Revenue growth: -5.1% YoY
- • Profit growth: -1.9% YoY
- • RSI: 19
- • MACD: bearish
Key risks
- • Momentum is fading versus the broader market
- • Revenue growth: -5.1% YoY
- • Profit growth: -1.9% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹130.59). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.